
Please try another search
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.
Name | Age | Since | Title |
---|---|---|---|
Lihan Zhou | 41 | 2020 | Co-Founder, CEO & Executive Director |
Heng Phon Too | 65 | 2021 | Chairman of the Board & Chairman of Scientific Advisory Board |
Ruiyang Zou | 39 | 2020 | Co-Founder, Deputy CEO, CTO & Executive Director |
Frank J. Slack | - | - | Member of Scientific Advisory Board |
Khay Guan Yeoh | - | - | Member of Scientific Advisory Board |
Hou Chiat Ho | 49 | 2020 | Chief Investment Officer & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review